WELCOME TO The PHARMACEUTICAL REPORT
The Issues and Regulation of Pharmaceutical Waste Management
I'm For Real
Enter your details once to access all our information and resources
At Allchem Pharma our expertise lies in the sourcing and supply of raw materials and ingredients to manufacturers of pharmaceutical, nutraceutical, veterinarian, medical and supplement products.
whitePaper | May 11, 2022
CDER is taking another step towards realizing the vision for pharmaceutical quality in the 21st century: a maximally efficient, agile, flexible manufacturing sector that reliably
produces high-quality drug products without extensive regulatory oversight.
whitePaper | April 7, 2021
In less than a week, in the face of a pandemic, the pharmaceutical sales model changed forever. In-person healthcare provider (HCP) visits came to a screeching halt and brand marketers scrambled to find ways to educate and engage these providers remotely. While the pandemic may have taken us by surprise, we should acknowledge that, even before the pandemic, pharmaceutical sales teams faced significant challenges.
One solution for these challenges is to engage HCPs – virtually.
whitePaper | March 16, 2020
With the rapid onset of coronavirus in the United States, many pharma companies are being forced to prepare for a scenario in which their reps cannot visit providers and patients are limited in their ability to visit their healthcare professionals (HCP). The CDC has gone as far as recommending the use of telemedicine and patient portals as primary channels for HCPs and patients to interact.
whitePaper | February 24, 2022
The COVID-19 pandemic and resulting economic dislocation revealed long-standing vulnerabilities in our
supply chains. The pandemic’s drastic impacts on demand patterns for a range of medical products including
essential medicines wreaked havoc on the U.S. healthcare system.
whitePaper | February 5, 2022
Essential medicine access is one of the main objectives of healthcare systems in and pharmaceutical supply chains
ensure that the right amount of medicine, with acceptable quality, will reach the customers in need
whitePaper | April 12, 2022
The level of pharmaceutical expenditure is closely watched and often commented upon, but the composition of that expenditure and its dynamics are not as well understood.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE